Health In Tech (HIT) Fundamental Analysis: Revenue, Earnings & Valuation

6.14 / 10

Outperform

Fundamental analysis rates HIT Outperform with a 6.1/10 score. Strengths include high accounts‑receivable turnover (20.5), fixed‑asset turnover (142), strong current ratio (2.87), robust interest coverage (15.6) and 94% profit growth. Weaknesses are low diluted EPS growth and negative Asset‑MV, yet overall fundamentals remain solid.

Analysis Checks(8/10)

Revenue-MV

Value-1.35

Score3/3

Weight15.43%

1M Return4.39%

Net profit attributable to parent company shareholders / Net profit (%)

Value100.00

Score3/3

Weight11.18%

1M Return2.92%

Accounts receivable turnover ratio

Value20.53

Score3/3

Weight10.05%

1M Return2.64%

Cash-UP

Value-1.35

Score3/3

Weight14.62%

1M Return4.55%

Fixed assets turnover ratio

Value142.10

Score3/3

Weight9.27%

1M Return2.46%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight9.16%

1M Return2.44%

Diluted earnings per share (YoY growth rate %)

Value50.00

Score1/3

Weight7.15%

1M Return2.00%

Asset-MV

Value-0.48

Score0/3

Weight-1.61%

1M Return-0.57%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value94.13

Score2/3

Weight15.19%

1M Return3.66%

Current ratio

Value2.87

Score3/3

Weight9.55%

1M Return2.53%

Is HIT undervalued or overvalued?

HIT scores 6.14/10 on fundamentals and holds a Discounted valuation at present. Backed by its 10.43% ROE, 4.68% net margin, 73.85 P/E ratio, 6.19 P/B ratio, and -50.00% earnings growth, these metrics solidify its Outperform investment rating.